Charles Schwab Investment Management Inc Innoviva, Inc. Transaction History

Charles Schwab Investment Management Inc

  • $515 Billion
  • Q3 2024

A detailed history of Charles Schwab Investment Management Inc transactions in Innoviva, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 732,296 shares of INVA stock, worth $14 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
732,296
Previous 831,062 11.88%
Holding current value
$14 Million
Previous $13.6 Million 3.7%
% of portfolio
0.0%
Previous 0.0%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024
SELL
$16.33 - $20.04 $1.61 Million - $1.98 Million
-98,766 Reduced 11.88%
732,296 $14.1 Million
Q2 2024

Aug 12, 2024
SELL
$14.4 - $16.4 $1.41 Million - $1.6 Million
-97,601 Reduced 10.51%
831,062 $13.6 Million
Q1 2024

May 08, 2024
SELL
$14.56 - $16.78 $66,917 - $77,120
-4,596 Reduced 0.49%
928,663 $14.2 Million
Q4 2023

Feb 06, 2024
BUY
$12.32 - $16.27 $1.67 Million - $2.2 Million
135,456 Added 16.98%
933,259 $15 Million
Q3 2023

Nov 08, 2023
BUY
$12.37 - $13.89 $1.42 Million - $1.6 Million
115,009 Added 16.84%
797,803 $10.4 Million
Q2 2023

Aug 09, 2023
BUY
$11.39 - $13.72 $1.1 Million - $1.32 Million
96,246 Added 16.41%
682,794 $8.69 Million
Q1 2023

May 11, 2023
BUY
$10.73 - $13.6 $1.23 Million - $1.56 Million
114,614 Added 24.29%
586,548 $6.6 Million
Q4 2022

Feb 13, 2023
BUY
$11.8 - $13.78 $91,792 - $107,194
7,779 Added 1.68%
471,934 $6.25 Million
Q3 2022

Nov 14, 2022
BUY
$11.61 - $15.22 $174,393 - $228,619
15,021 Added 3.34%
464,155 $5.39 Million
Q2 2022

Aug 15, 2022
BUY
$14.32 - $19.88 $506,025 - $702,499
35,337 Added 8.54%
449,134 $6.63 Million
Q1 2022

May 13, 2022
SELL
$15.39 - $20.25 $1.63 Million - $2.15 Million
-105,940 Reduced 20.38%
413,797 $8.01 Million
Q4 2021

Feb 11, 2022
SELL
$15.91 - $18.72 $219,987 - $258,841
-13,827 Reduced 2.59%
519,737 $8.97 Million
Q3 2021

Nov 16, 2021
SELL
$13.06 - $17.24 $247,813 - $327,128
-18,975 Reduced 3.43%
533,564 $8.92 Million
Q2 2021

Aug 16, 2021
BUY
$11.45 - $13.96 $76,348 - $93,085
6,668 Added 1.22%
552,539 $7.41 Million
Q1 2021

May 17, 2021
BUY
$11.06 - $12.87 $961,368 - $1.12 Million
86,923 Added 18.94%
545,871 $6.52 Million
Q4 2020

Feb 16, 2021
BUY
$9.33 - $12.48 $376,848 - $504,079
40,391 Added 9.65%
458,948 $5.69 Million
Q3 2020

Nov 13, 2020
SELL
$10.33 - $14.49 $206,042 - $289,017
-19,946 Reduced 4.55%
418,557 $4.37 Million
Q2 2020

Aug 14, 2020
BUY
$11.49 - $15.26 $298,717 - $396,729
25,998 Added 6.3%
438,503 $6.13 Million
Q1 2020

May 15, 2020
BUY
$8.11 - $15.23 $42,609 - $80,018
5,254 Added 1.29%
412,505 $4.85 Million
Q4 2019

Feb 07, 2020
BUY
$10.28 - $14.38 $107,806 - $150,803
10,487 Added 2.64%
407,251 $5.77 Million
Q3 2019

Nov 08, 2019
BUY
$10.05 - $14.55 $71,907 - $104,105
7,155 Added 1.84%
396,764 $4.18 Million
Q2 2019

Aug 09, 2019
SELL
$13.1 - $14.95 $1.44 Million - $1.65 Million
-110,078 Reduced 22.03%
389,609 $5.67 Million
Q1 2019

May 14, 2019
SELL
$13.69 - $20.06 $1.36 Million - $1.99 Million
-99,278 Reduced 16.57%
499,687 $7.01 Million
Q4 2018

Feb 14, 2019
SELL
$13.96 - $18.26 $1.78 Million - $2.33 Million
-127,471 Reduced 17.55%
598,965 $10.5 Million
Q3 2018

Nov 13, 2018
BUY
$13.63 - $15.7 $914,368 - $1.05 Million
67,085 Added 10.17%
726,436 $11.1 Million
Q2 2018

Aug 08, 2018
BUY
$13.44 - $17.59 $3.18 Million - $4.16 Million
236,671 Added 55.99%
659,351 $9.1 Million
Q1 2018

May 07, 2018
BUY
$13.8 - $16.99 $58,374 - $71,867
4,230 Added 1.01%
422,680 $7.05 Million
Q4 2017

Jan 17, 2018
BUY
$11.73 - $14.75 $818,167 - $1.03 Million
69,750 Added 20.0%
418,450 $5.94 Million
Q3 2017

Nov 13, 2017
BUY
$12.06 - $14.12 $4.21 Million - $4.92 Million
348,700
348,700 $4.92 Million

Others Institutions Holding INVA

# of Institutions
229
Shares Held
79.2M
Call Options Held
37.6K
Put Options Held
300
View Full List

About Innoviva, Inc.

INVA Quotes by TradingView
  • Ticker INVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 69,706,000
  • Market Cap $1.33B
  • Description
  • Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...
More about INVA
Track This Portfolio

Track Charles Schwab Investment Management Inc Portfolio

Follow Charles Schwab Investment Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email